0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dental Anesthetic Drug Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-13W17120
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dental Anesthetic Drug Market Research Report 2024
BUY CHAPTERS

Global Dental Anesthetic Drug Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-13W17120
Report
November 2025
Pages:157
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dental Anesthetic Drug Market

The global Dental Anesthetic Drug market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Dental anesthesia drugs are drugs used by dentists to anesthetize the mouth and surrounding tissues to reduce or eliminate the patient's pain when performing oral surgery or treatment.
With the continuous advancement of medical technology and the growing demand for oral health and comfortable treatment experience, dental anesthetic drugs have a bright future.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dental Anesthetic Drug market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Dental Anesthetic Drug Market Report

Report Metric Details
Report Name Dental Anesthetic Drug Market
Segment by Type
  • Procaine
  • Lidocaine
  • Bupivacaine
  • Tetracaine
Segment by Application
  • Hospital
  • Dental Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pierre, Balanced Pharma, INIBSA, HANSAmed Limited, Exir Pharmaceutical Company, Laboratorios Inibsa, Septodont, Laboratorios Normon, Primex Pharmaceuticals, ASPEN Group, 3M Company, Dentsply
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Dental Anesthetic Drug study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Dental Anesthetic Drug Market report?

Ans: The main players in the Dental Anesthetic Drug Market are Pierre, Balanced Pharma, INIBSA, HANSAmed Limited, Exir Pharmaceutical Company, Laboratorios Inibsa, Septodont, Laboratorios Normon, Primex Pharmaceuticals, ASPEN Group, 3M Company, Dentsply

What are the Application segmentation covered in the Dental Anesthetic Drug Market report?

Ans: The Applications covered in the Dental Anesthetic Drug Market report are Hospital, Dental Clinic, Others

What are the Type segmentation covered in the Dental Anesthetic Drug Market report?

Ans: The Types covered in the Dental Anesthetic Drug Market report are Procaine, Lidocaine, Bupivacaine, Tetracaine

1 Study Coverage
1.1 Introduction to Dental Anesthetic Drug: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dental Anesthetic Drug Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Procaine
1.2.3 Lidocaine
1.2.4 Bupivacaine
1.2.5 Tetracaine
1.3 Market Segmentation by Application
1.3.1 Global Dental Anesthetic Drug Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Dental Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dental Anesthetic Drug Revenue Estimates and Forecasts 2020-2031
2.2 Global Dental Anesthetic Drug Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Dental Anesthetic Drug Sales Estimates and Forecasts 2020-2031
2.4 Global Dental Anesthetic Drug Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Dental Anesthetic Drug Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Dental Anesthetic Drug Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Procaine Market Size by Manufacturers
3.5.2 Lidocaine Market Size by Manufacturers
3.5.3 Bupivacaine Market Size by Manufacturers
3.5.4 Tetracaine Market Size by Manufacturers
3.6 Global Dental Anesthetic Drug Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dental Anesthetic Drug Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Dental Anesthetic Drug Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dental Anesthetic Drug Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Dental Anesthetic Drug Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Dental Anesthetic Drug Sales and Revenue by Type (2020-2031)
6.4 North America Dental Anesthetic Drug Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dental Anesthetic Drug Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Dental Anesthetic Drug Sales and Revenue by Type (2020-2031)
7.4 Europe Dental Anesthetic Drug Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dental Anesthetic Drug Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Dental Anesthetic Drug Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Dental Anesthetic Drug Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Dental Anesthetic Drug Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Dental Anesthetic Drug Sales and Revenue by Type (2020-2031)
9.4 Central and South America Dental Anesthetic Drug Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dental Anesthetic Drug Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Dental Anesthetic Drug Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Dental Anesthetic Drug Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dental Anesthetic Drug Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pierre
11.1.1 Pierre Corporation Information
11.1.2 Pierre Business Overview
11.1.3 Pierre Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.1.4 Pierre Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Pierre Dental Anesthetic Drug Sales by Product in 2024
11.1.6 Pierre Dental Anesthetic Drug Sales by Application in 2024
11.1.7 Pierre Dental Anesthetic Drug Sales by Geographic Area in 2024
11.1.8 Pierre Dental Anesthetic Drug SWOT Analysis
11.1.9 Pierre Recent Developments
11.2 Balanced Pharma
11.2.1 Balanced Pharma Corporation Information
11.2.2 Balanced Pharma Business Overview
11.2.3 Balanced Pharma Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.2.4 Balanced Pharma Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Balanced Pharma Dental Anesthetic Drug Sales by Product in 2024
11.2.6 Balanced Pharma Dental Anesthetic Drug Sales by Application in 2024
11.2.7 Balanced Pharma Dental Anesthetic Drug Sales by Geographic Area in 2024
11.2.8 Balanced Pharma Dental Anesthetic Drug SWOT Analysis
11.2.9 Balanced Pharma Recent Developments
11.3 INIBSA
11.3.1 INIBSA Corporation Information
11.3.2 INIBSA Business Overview
11.3.3 INIBSA Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.3.4 INIBSA Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 INIBSA Dental Anesthetic Drug Sales by Product in 2024
11.3.6 INIBSA Dental Anesthetic Drug Sales by Application in 2024
11.3.7 INIBSA Dental Anesthetic Drug Sales by Geographic Area in 2024
11.3.8 INIBSA Dental Anesthetic Drug SWOT Analysis
11.3.9 INIBSA Recent Developments
11.4 HANSAmed Limited
11.4.1 HANSAmed Limited Corporation Information
11.4.2 HANSAmed Limited Business Overview
11.4.3 HANSAmed Limited Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.4.4 HANSAmed Limited Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 HANSAmed Limited Dental Anesthetic Drug Sales by Product in 2024
11.4.6 HANSAmed Limited Dental Anesthetic Drug Sales by Application in 2024
11.4.7 HANSAmed Limited Dental Anesthetic Drug Sales by Geographic Area in 2024
11.4.8 HANSAmed Limited Dental Anesthetic Drug SWOT Analysis
11.4.9 HANSAmed Limited Recent Developments
11.5 Exir Pharmaceutical Company
11.5.1 Exir Pharmaceutical Company Corporation Information
11.5.2 Exir Pharmaceutical Company Business Overview
11.5.3 Exir Pharmaceutical Company Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.5.4 Exir Pharmaceutical Company Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Exir Pharmaceutical Company Dental Anesthetic Drug Sales by Product in 2024
11.5.6 Exir Pharmaceutical Company Dental Anesthetic Drug Sales by Application in 2024
11.5.7 Exir Pharmaceutical Company Dental Anesthetic Drug Sales by Geographic Area in 2024
11.5.8 Exir Pharmaceutical Company Dental Anesthetic Drug SWOT Analysis
11.5.9 Exir Pharmaceutical Company Recent Developments
11.6 Laboratorios Inibsa
11.6.1 Laboratorios Inibsa Corporation Information
11.6.2 Laboratorios Inibsa Business Overview
11.6.3 Laboratorios Inibsa Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.6.4 Laboratorios Inibsa Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Laboratorios Inibsa Recent Developments
11.7 Septodont
11.7.1 Septodont Corporation Information
11.7.2 Septodont Business Overview
11.7.3 Septodont Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.7.4 Septodont Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Septodont Recent Developments
11.8 Laboratorios Normon
11.8.1 Laboratorios Normon Corporation Information
11.8.2 Laboratorios Normon Business Overview
11.8.3 Laboratorios Normon Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.8.4 Laboratorios Normon Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Laboratorios Normon Recent Developments
11.9 Primex Pharmaceuticals
11.9.1 Primex Pharmaceuticals Corporation Information
11.9.2 Primex Pharmaceuticals Business Overview
11.9.3 Primex Pharmaceuticals Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.9.4 Primex Pharmaceuticals Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Primex Pharmaceuticals Recent Developments
11.10 ASPEN Group
11.10.1 ASPEN Group Corporation Information
11.10.2 ASPEN Group Business Overview
11.10.3 ASPEN Group Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.10.4 ASPEN Group Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 ASPEN Group Recent Developments
11.11 3M Company
11.11.1 3M Company Corporation Information
11.11.2 3M Company Business Overview
11.11.3 3M Company Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.11.4 3M Company Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 3M Company Recent Developments
11.12 Dentsply
11.12.1 Dentsply Corporation Information
11.12.2 Dentsply Business Overview
11.12.3 Dentsply Dental Anesthetic Drug Product Models, Descriptions and Specifications
11.12.4 Dentsply Dental Anesthetic Drug Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Dentsply Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Dental Anesthetic Drug Industry Chain
12.2 Dental Anesthetic Drug Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Dental Anesthetic Drug Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Dental Anesthetic Drug Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dental Anesthetic Drug Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dental Anesthetic Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Dental Anesthetic Drug Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Dental Anesthetic Drug Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Dental Anesthetic Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Dental Anesthetic Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Dental Anesthetic Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Dental Anesthetic Drug Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Dental Anesthetic Drug Sales by Region (2020-2025) & (K Units)
 Table 8. Global Dental Anesthetic Drug Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Dental Anesthetic Drug Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Dental Anesthetic Drug Sales Share by Manufacturers (2020-2025)
 Table 12. Global Dental Anesthetic Drug Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Dental Anesthetic Drug Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Dental Anesthetic Drug by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dental Anesthetic Drug as of 2024)
 Table 16. Global Dental Anesthetic Drug Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Dental Anesthetic Drug Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Dental Anesthetic Drug Manufacturing Base and Headquarters
 Table 19. Global Dental Anesthetic Drug Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Dental Anesthetic Drug Sales by Type (2020-2025) & (K Units)
 Table 23. Global Dental Anesthetic Drug Sales by Type (2026-2031) & (K Units)
 Table 24. Global Dental Anesthetic Drug Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Dental Anesthetic Drug Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Dental Anesthetic Drug ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Dental Anesthetic Drug Sales by Application (2020-2025) & (K Units)
 Table 29. Global Dental Anesthetic Drug Sales by Application (2026-2031) & (K Units)
 Table 30. Dental Anesthetic Drug High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Dental Anesthetic Drug Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Dental Anesthetic Drug Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Dental Anesthetic Drug ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Dental Anesthetic Drug Growth Accelerators and Market Barriers
 Table 37. North America Dental Anesthetic Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Dental Anesthetic Drug Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Dental Anesthetic Drug Growth Accelerators and Market Barriers
 Table 40. Europe Dental Anesthetic Drug Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Dental Anesthetic Drug Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Dental Anesthetic Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Dental Anesthetic Drug Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Dental Anesthetic Drug Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Dental Anesthetic Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Dental Anesthetic Drug Investment Opportunities and Key Challenges
 Table 47. Central and South America Dental Anesthetic Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Dental Anesthetic Drug Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Dental Anesthetic Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Pierre Corporation Information
 Table 51. Pierre Description and Major Businesses
 Table 52. Pierre Product Models, Descriptions and Specifications
 Table 53. Pierre Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Pierre Sales Value Proportion by Product in 2024
 Table 55. Pierre Sales Value Proportion by Application in 2024
 Table 56. Pierre Sales Value Proportion by Geographic Area in 2024
 Table 57. Pierre Dental Anesthetic Drug SWOT Analysis
 Table 58. Pierre Recent Developments
 Table 59. Balanced Pharma Corporation Information
 Table 60. Balanced Pharma Description and Major Businesses
 Table 61. Balanced Pharma Product Models, Descriptions and Specifications
 Table 62. Balanced Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Balanced Pharma Sales Value Proportion by Product in 2024
 Table 64. Balanced Pharma Sales Value Proportion by Application in 2024
 Table 65. Balanced Pharma Sales Value Proportion by Geographic Area in 2024
 Table 66. Balanced Pharma Dental Anesthetic Drug SWOT Analysis
 Table 67. Balanced Pharma Recent Developments
 Table 68. INIBSA Corporation Information
 Table 69. INIBSA Description and Major Businesses
 Table 70. INIBSA Product Models, Descriptions and Specifications
 Table 71. INIBSA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. INIBSA Sales Value Proportion by Product in 2024
 Table 73. INIBSA Sales Value Proportion by Application in 2024
 Table 74. INIBSA Sales Value Proportion by Geographic Area in 2024
 Table 75. INIBSA Dental Anesthetic Drug SWOT Analysis
 Table 76. INIBSA Recent Developments
 Table 77. HANSAmed Limited Corporation Information
 Table 78. HANSAmed Limited Description and Major Businesses
 Table 79. HANSAmed Limited Product Models, Descriptions and Specifications
 Table 80. HANSAmed Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. HANSAmed Limited Sales Value Proportion by Product in 2024
 Table 82. HANSAmed Limited Sales Value Proportion by Application in 2024
 Table 83. HANSAmed Limited Sales Value Proportion by Geographic Area in 2024
 Table 84. HANSAmed Limited Dental Anesthetic Drug SWOT Analysis
 Table 85. HANSAmed Limited Recent Developments
 Table 86. Exir Pharmaceutical Company Corporation Information
 Table 87. Exir Pharmaceutical Company Description and Major Businesses
 Table 88. Exir Pharmaceutical Company Product Models, Descriptions and Specifications
 Table 89. Exir Pharmaceutical Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Exir Pharmaceutical Company Sales Value Proportion by Product in 2024
 Table 91. Exir Pharmaceutical Company Sales Value Proportion by Application in 2024
 Table 92. Exir Pharmaceutical Company Sales Value Proportion by Geographic Area in 2024
 Table 93. Exir Pharmaceutical Company Dental Anesthetic Drug SWOT Analysis
 Table 94. Exir Pharmaceutical Company Recent Developments
 Table 95. Laboratorios Inibsa Corporation Information
 Table 96. Laboratorios Inibsa Description and Major Businesses
 Table 97. Laboratorios Inibsa Product Models, Descriptions and Specifications
 Table 98. Laboratorios Inibsa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Laboratorios Inibsa Recent Developments
 Table 100. Septodont Corporation Information
 Table 101. Septodont Description and Major Businesses
 Table 102. Septodont Product Models, Descriptions and Specifications
 Table 103. Septodont Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Septodont Recent Developments
 Table 105. Laboratorios Normon Corporation Information
 Table 106. Laboratorios Normon Description and Major Businesses
 Table 107. Laboratorios Normon Product Models, Descriptions and Specifications
 Table 108. Laboratorios Normon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Laboratorios Normon Recent Developments
 Table 110. Primex Pharmaceuticals Corporation Information
 Table 111. Primex Pharmaceuticals Description and Major Businesses
 Table 112. Primex Pharmaceuticals Product Models, Descriptions and Specifications
 Table 113. Primex Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Primex Pharmaceuticals Recent Developments
 Table 115. ASPEN Group Corporation Information
 Table 116. ASPEN Group Description and Major Businesses
 Table 117. ASPEN Group Product Models, Descriptions and Specifications
 Table 118. ASPEN Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. ASPEN Group Recent Developments
 Table 120. 3M Company Corporation Information
 Table 121. 3M Company Description and Major Businesses
 Table 122. 3M Company Product Models, Descriptions and Specifications
 Table 123. 3M Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. 3M Company Recent Developments
 Table 125. Dentsply Corporation Information
 Table 126. Dentsply Description and Major Businesses
 Table 127. Dentsply Product Models, Descriptions and Specifications
 Table 128. Dentsply Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Dentsply Recent Developments
 Table 130. Key Raw Materials Distribution
 Table 131. Raw Materials Key Suppliers
 Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 133. Milestones in Production Technology Evolution
 Table 134. Distributors List
 Table 135. Market Trends and Market Evolution
 Table 136. Market Drivers and Opportunities
 Table 137. Market Challenges, Risks, and Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Dental Anesthetic Drug Product Picture
 Figure 2. Global Dental Anesthetic Drug Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Procaine Product Picture
 Figure 4. Lidocaine Product Picture
 Figure 5. Bupivacaine Product Picture
 Figure 6. Tetracaine Product Picture
 Figure 7. Global Dental Anesthetic Drug Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Hospital
 Figure 9. Dental Clinic
 Figure 10. Others
 Figure 11. Dental Anesthetic Drug Report Years Considered
 Figure 12. Global Dental Anesthetic Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Dental Anesthetic Drug Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Dental Anesthetic Drug Revenue Market Share by Region (2020-2031)
 Figure 16. Global Dental Anesthetic Drug Sales (2020-2031) & (K Units)
 Figure 17. Global Dental Anesthetic Drug Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 18. Global Dental Anesthetic Drug Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Dental Anesthetic Drug Sales Volume Market Share in 2024
 Figure 20. Global Dental Anesthetic Drug Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Procaine Revenue Market Share by Manufacturer in 2024
 Figure 23. Lidocaine Revenue Market Share by Manufacturer in 2024
 Figure 24. Bupivacaine Revenue Market Share by Manufacturer in 2024
 Figure 25. Tetracaine Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Dental Anesthetic Drug Sales Market Share by Type (2020-2031)
 Figure 27. Global Dental Anesthetic Drug Revenue Market Share by Type (2020-2031)
 Figure 28. Global Dental Anesthetic Drug Sales Market Share by Application (2020-2031)
 Figure 29. Global Dental Anesthetic Drug Revenue Market Share by Application (2020-2031)
 Figure 30. North America Dental Anesthetic Drug Sales YoY (2020-2031) & (K Units)
 Figure 31. North America Dental Anesthetic Drug Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Dental Anesthetic Drug Sales Revenue (US$ Million) in 2024
 Figure 33. North America Dental Anesthetic Drug Sales Volume (K Units) by Type (2020- 2031)
 Figure 34. North America Dental Anesthetic Drug Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America Dental Anesthetic Drug Sales Volume (K Units) by Application (2020-2031)
 Figure 36. North America Dental Anesthetic Drug Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Dental Anesthetic Drug Sales YoY (2020-2031) & (K Units)
 Figure 41. Europe Dental Anesthetic Drug Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Dental Anesthetic Drug Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Dental Anesthetic Drug Sales Volume (K Units) by Type (2020-2031)
 Figure 44. Europe Dental Anesthetic Drug Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe Dental Anesthetic Drug Sales Volume (K Units) by Application (2020-2031)
 Figure 46. Europe Dental Anesthetic Drug Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 48. France Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Dental Anesthetic Drug Sales YoY (2020-2031) & (K Units)
 Figure 53. Asia-Pacific Dental Anesthetic Drug Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Dental Anesthetic Drug Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Dental Anesthetic Drug Sales Volume (K Units) by Type (2020- 2031)
 Figure 56. Asia-Pacific Dental Anesthetic Drug Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific Dental Anesthetic Drug Sales Volume (K Units) by Application (2020-2031)
 Figure 58. Asia-Pacific Dental Anesthetic Drug Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 63. India Dental Anesthetic Drug Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Dental Anesthetic Drug Sales YoY (2020-2031) & (K Units)
 Figure 65. Central and South America Dental Anesthetic Drug Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Dental Anesthetic Drug Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Dental Anesthetic Drug Sales Volume (K Units) by Type (2021-2031)
 Figure 68. Central and South America Dental Anesthetic Drug Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America Dental Anesthetic Drug Sales Volume (K Units) by Application (2020-2031)
 Figure 70. Central and South America Dental Anesthetic Drug Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Dental Anesthetic Drug Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Dental Anesthetic Drug Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Dental Anesthetic Drug Sales YoY (2020-2031) & (K Units)
 Figure 74. Middle East and Africa Dental Anesthetic Drug Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Dental Anesthetic Drug Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Dental Anesthetic Drug Sales Volume (K Units) by Type (2021-2031)
 Figure 77. South America Dental Anesthetic Drug Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa Dental Anesthetic Drug Sales Volume (K Units) by Application (2020-2031)
 Figure 79. Middle East and Africa Dental Anesthetic Drug Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Dental Anesthetic Drug Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Dental Anesthetic Drug Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Dental Anesthetic Drug Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Dental Anesthetic Drug Revenue (2020-2025) & (US$ Million)
 Figure 84. Dental Anesthetic Drug Industry Chain Mapping
 Figure 85. Regional Dental Anesthetic Drug Manufacturing Base Distribution (%)
 Figure 86. Global Dental Anesthetic Drug Production Market Share by Region (2020-2031)
 Figure 87. Dental Anesthetic Drug Production Process
 Figure 88. Regional Dental Anesthetic Drug Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart